Results 161 to 170 of about 198,261 (297)

Eosinophilic inflammation in hereditary angioedema: a single-center real-world retrospective chart review study. [PDF]

Front Immunol
Boch K, Ludwig RJ, von Bubnoff D, Recke A.   +3 more
europepmc   +1 more source

Colonic left‐side increase of eosinophils: a clue to drug‐related colitis in adults [PDF]

, 2008
Giovanni Casella, Vincenzo Villanacci, Simona Fisogni, A. Cambareri, Camillo Di Bella, Nadia Corazzi, Seema Rao Gorla, Vittorio Baldini, Gabrio Bassotti   +8 more
openalex   +1 more source

Intraosseous sarcoidosis imitating peri‐implantitis: A case study

Clinical Advances in Periodontics, EarlyView.
Abstract Background Sarcoidosis is a multisystem granulomatous disorder of unknown cause, typically affecting the lungs and lymph nodes, but it can also involve the eyes, skin, heart, bones, and other organs. The exact cause is unclear, but genetic factors and environmental triggers like infections, chemicals, or dust may play a role.
Magdalena Orlowska, David S. Gottlieb, Kenneth S. Kornman   +2 more
wiley   +1 more source

Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils. [PDF]

Pediatr Allergy Immunol
Gautam R, Lal M, Carroll MC, Mrozek Z, Trachsel T, Beers J, Ruffner MA.   +6 more
europepmc   +1 more source

Neutrophil- and eosinophil extracellular traps (NETs and EETs) in small, medium, and large vessel vasculitis

, 2016

openalex   +1 more source

Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis

Clinical Pharmacology &Therapeutics, EarlyView.
Dupilumab, a fully human monoclonal antibody that blocks key drivers of type 2 inflammation, is approved across 8 diseases, including eosinophilic esophagitis. Subcutaneous dupilumab 300 mg weekly improved outcomes vs. placebo in adults (aged ≥ 18 years) and adolescents (aged ≥ 12 to < 18 years) during the phase III LIBERTY EoE TREET study (NCT03633617)
Jenny‐Hoa Nguyen, Mirna Chehade, Evan S. Dellon, Allen Radin, Jason Chittenden, Mohamed A. Kamal, Margee Louisias, Christine Xu, Matthew P. Kosloski   +8 more
wiley   +1 more source

Surface expression of CD63 and HLA-DR in circulating eosinophils correlates with improved clinical control after treatment optimization in asthma. [PDF]

Sci Rep
Scarlata S, Mazzuca C, Vitiello L, Finamore P, Coppola A, Maurizi F, Travaglini S, Zito A, Fontana D, Incalzi RA.   +9 more
europepmc   +1 more source

Association of the blood eosinophil count with hematological malignancies and mortality [PDF]

, 2014
Christen Lykkegaard Andersen, Volkert Siersma, Hans Carl Hasselbalch, Hanne Vestergaard, Ruben A. Mesa, Peter Felding, Niels de Fine Olivarius, Ole Weis Bjerrum   +7 more
openalex   +1 more source

Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma

American Journal of Respiratory and Critical Care Medicine, 2017
E. A. Kelly, S. Esnault, Lin Ying Liu, M. Evans, M. Johansson, S. Mathur, D. Mosher, Loren C. Denlinger, N. Jarjour   +8 more
semanticscholar   +1 more source

Exercise affects systemic basophil responses in humans: Applying an automated and modified basophil activation test (mBAT) in a field study

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Basophils are effector cells in type I hypersensitivity reactions. Upon cross‐linking of surface‐bound (allergen‐specific) IgE, basophils release a variety of mediators. Determining the activation of basophils ex vivo with anti‐IgE (a basophil activation test or BAT) can be achieved using flow cytometry.
T. C. Pelgrim, B. N. Jukema, L. Koopmans, C. C. W. G. Bongers, M. T. E. Hopman, E. F. Knol, N. Vrisekoop, L. Koenderman   +7 more
wiley   +1 more source